Getting a handle on bipolar disorder is like riding a roller coaster with both patients and physicians — all hollering for stability. There is no diagnostic test to confirm bipolar disorder, and choosing the optimal drug therapy is a frustrating odyssey of trial and error. Manic episodes of overly excited states can quickly slide into states of deep depression. And some antidepressants, while effective in one individual, can trigger new rounds of uncontrollable mania in another.
Mark Frye, M.D., combines basic and clinical research with psychiatric practice and his new role as department chair.
Mayo Clinic psychiatry researchers are investigating ways to end the roller coaster ride, or at least to eliminate some of its rushes and surges. Mark Frye, M.D., is using genotyping and brain scans in research to hopefully one day match the genetic profile of newly diagnosed patients with the most effective and least harmful drug to treat bipolar disorder.
For journalists seeking interviews on Bipolar Disorder, please contact Rebecca Eisenman at 507-284-5005.